Lee Ainslie - Maverick Capital
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2024 Q2 | 7,849 | 0.02 | Add 272.87% | 0.01 | $142.69 |
| 2024 Q1 | 2,105 | 0.01 | Buy | 0.01 | $128.27 |
| 2023 Q2 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2023 Q1 | 4,312 | 0.01 | Reduce 6.42% | 0.00 | $79.55 |
| 2022 Q4 | 4,608 | 0.01 | Reduce 6.91% | 0.00 | $67.71 |
| 2022 Q3 | 4,950 | 0.01 | Buy | 0.01 | $49.90 |
| 2021 Q1 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2020 Q4 | 5,316 | 0.00 | Reduce 70.25% | 0.00 | $34.99 |
| 2020 Q3 | 17,866 | 0.01 | Buy | 0.01 | $34.70 |